Aug 14 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* NUVO PHARMACEUTICALS INC - Q2 ADJUSTED TOTAL REVENUE - $19.1 MILLION
* NUVO PHARMACEUTICALS INC - Q2 ADJUSTED EBITDA - $5.7 MILLION
* NUVO PHARMACEUTICALS INC - Q2 GROSS PROFIT - $9.6 MILLION
* NUVO PHARMACEUTICALS INC - CASH AND SHORT-TERM INVESTMENTS WERE $14.7 MILLION AS AT JUNE 30, 2019 COMPARED TO $28.1 MILLION AS AT DECEMBER 31, 2018